MGI Tech Announces Acquisition of STOmics and CycloneSEQ to Deliver Integrated Long-Read, Short-Read and Spatial Omics Solutions
SHENZHEN, China, March 4, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company dedicated to developing core tools and technologies that drive innovation in the life sciences, today announced the acquisition of STOmics and CycloneSEQ. It marks...
Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026
In Partnership with ATC Genomics, the Company Presented One of Asia's Largest Real-World Datasets (n=12,281) for AI-Powered Multi-Cancer Early Detection (MCED) and Showcased its Clinically Validated ctDNA-Powered Oncology Portfolio Across the Full...
VIA Labs Announces Availability of Industrial-Grade USB 5Gbps and 10Gbps Hub Controllers at Embedded World 2026
NUREMBERG, Germany, March 4, 2026 /PRNewswire/ -- VIA Labs, Inc. (VLI), a leading supplier of USB4, DisplayPort, SuperSpeed USB, USB 2.0, and USB Power Delivery Controllers, today announced at Embedded World 2026 the expansion of its industrial...
Locksley Announces High-Grade Antimony Assays at Desert Antimony Mine Confirm Surface Continuity
SAN BERNARDINO, Calif., March 3, 2026 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY; OTCQX: LKYRF/ADR: LKYLY announced high-grade antimony (Sb) assays received from surface exposure grab sampling, with a peak value of 16.90% Sb confirm...
Akash Systems Announces World's First Diamond Cooled AI Servers with AMD Instinct™ MI350X GPUs and MiTAC Computing
Breakthrough Diamond Cooling® technology creates the most energy and capital-efficient AI servers in the world Akash's Diamond Cooling® solution is a new innovation in cooling technology that is additive to existing air and liquid cooling...
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
First glucokinase-activator (GKA) approval outside mainland China Approval supports a differentiated approach to T ype 2 diabetes (T2D) management Hong Kong will serve as H ua Medicine's launchpad for international market expansion SHANGHAI and HONG...
ReviR Therapeutics Announces First Participant Dosed in Phase 1 Study and Secures CDE Clearance for Two Orphan Indications in China, Supporting Future U.S. Expansion Strategy
Milestone marks the first clinical program for Charcot-Marie-Tooth disease and Vanishing White Matter disease. SAN FRANCISCO and SHANGHAI, March 2, 2026 /PRNewswire/ -- ReviR Therapeutics, a clinical-stage biotechnology company pioneering AI-driven...
Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair®
PHILADELPHIA, March 2, 2026 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. ("LongBio"), a clinical-stage biotech company focused on discovery and development of biologics targeting allergic and autoimmune diseases, proudly announced positive...
Halia Therapeutics Announces Presentation at the BIO Investment & Growth Summit
LEHI, Utah, March 2, 2026 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing therapies grounded in human biology, today announced that it will deliver a company presentation at the BIO Investment & Growth...
MDJM LTD Announces Journey to the West Officially Enters Production
A Prestigious European Production Team Leads the Project LONDON, March 2, 2026 /PRNewswire/ -- MDJM LTD (Nasdaq: UOKA) (the "Company" or "MDJM"), an integrated global culture-driven asset management company, today announced that the animated short...